Umb Bank, N.A. Regeneron Pharmaceuticals, Inc. Transaction History

Umb Bank, N.A.

$6.26 Billion
Q2 2025

A detailed history of Umb Bank, N.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 965 shares of REGN stock, worth $556,583. This represents 0.01% of its overall portfolio holdings.

Number of Shares

965

Previous 1,041 7.3%

Holding current value

$556,583

Previous $546,000 7.33%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	SELL	$483.07 - $625.6 $36,713 - $47,545	-76 Reduced 7.3%	965 $506,000
Q1 2025 Apr 14, 2025	BUY	$634.14 - $744.83 $99,559 - $116,938	157 Added 17.76%	1,041 $660,000
Q4 2024 Jan 16, 2025	SELL	$701.85 - $1046.91 $16,844 - $25,125	-24 Reduced 2.64%	884 $629,000
Q3 2024 Oct 08, 2024	BUY	$1024.09 - $1201.76 $10,240 - $12,017	10 Added 1.11%	908 $954,000
Q2 2024 Jul 29, 2024	BUY	$883.2 - $1071.19 $81,254 - $98,549	92 Added 11.41%	898 $943,000
Q4 2023 Jan 23, 2024	SELL	$775.18 - $881.7 $13,178 - $14,988	-17 Reduced 2.07%	806 $707,000
Q3 2023 Oct 18, 2023	SELL	$692.45 - $844.37 $103,867 - $126,655	-150 Reduced 15.42%	823 $677,000
Q2 2023 Jul 25, 2023	BUY	$700.03 - $830.35 $2,100 - $2,491	3 Added 0.31%	973 $699,000
Q1 2023 Apr 11, 2023	SELL	$680.49 - $826.97 $153,790 - $186,895	-226 Reduced 18.9%	970 $797,000
Q3 2022 Oct 13, 2022	SELL	$573.97 - $724.32 $573 - $724	-1 Reduced 0.08%	1,196 $824,000
Q2 2022 Jul 20, 2022	SELL	$548.35 - $738.84 $23,579 - $31,770	-43 Reduced 3.47%	1,197 $707,000
Q1 2022 Apr 22, 2022	BUY	$595.12 - $698.43 $25,590 - $30,032	43 Added 3.59%	1,240 $866,000
Q4 2021 Feb 09, 2022	BUY	$543.48 - $670.97 $339,675 - $419,356	625 Added 109.27%	1,197 $756,000
Q3 2021 Oct 18, 2021	SELL	$574.03 - $680.96 $3,444 - $4,085	-6 Reduced 1.04%	572 $346,000
Q2 2021 Jul 26, 2021	SELL	$472.8 - $558.54 $5.97 Million - $7.05 Million	-12,621 Reduced 95.62%	578 $323,000
Q1 2021 Apr 15, 2021	BUY	$446.73 - $548.2 $1.99 Million - $2.44 Million	4,455 Added 50.95%	13,199 $6.25 Million
Q4 2020 Feb 04, 2021	BUY	$478.3 - $607.98 $3.68 Million - $4.68 Million	7,691 Added 730.39%	8,744 $4.23 Million
Q2 2020 Jul 16, 2020	BUY	$493.32 - $643.92 $519,465 - $678,047	1,053 New	1,053 $657,000
Q4 2017 Jan 22, 2018	SELL	$358.63 - $469.95 $1.44 Million - $1.89 Million	-4,022 Closed	0 $0
Q3 2017 Oct 11, 2017	BUY	$431.38 - $504.0 $1.74 Million - $2.03 Million	4,022	4,022 $1.8 Million

Others Institutions Holding REGN

# of Institutions

1,423

Shares Held

88.8M

Call Options Held

1.98M

Put Options Held

1.75M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $61.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account